Levonorgestrel/Ethinylestradiol Cristers

Levonorgestrel/Ethinylestradiol, the active ingredient in Levonorgestrel/Ethinylestradiol Cristers, is a combined oral contraceptive presented as a tablet for oral use. It prevents pregnancy in women of reproductive age by inhibiting ovulation, thickening cervical mucus, and altering the endometrial lining.

GNH USA supplies Levonorgestrel/Ethinylestradiol Cristers as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levonorgestrel/Ethinylestradiol is a combined oral contraceptive used to prevent pregnancy by suppressing ovulation and altering cervical mucus.

- Contraception: prevents unintended pregnancy in women of child‑bearing potential. - Menstrual cycle regulation: helps establish regular monthly bleeding patterns. - Management of dysmenorrhea: reduces menstrual pain and associated cramps.

Levonorgestrel/Ethinylestradiol may cause a range of adverse reactions. Most are mild and transient, but rare serious events can occur.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: tension‑type or migraine‑like pain. - Breast tenderness: swelling or discomfort of the breasts. - Spotting: irregular light bleeding between periods.

Serious or Rare Side Effects: - Deep vein thrombosis: blood clot formation in deep veins. - Pulmonary embolism: clot migration to lung vessels. - Stroke or myocardial infarction: vascular events linked to clotting risk.

Before prescribing Levonorgestrel/Ethinylestradiol, clinicians should consider several safety factors.

- Cardiovascular risk assessment: avoid in women with a history of thromboembolic disorders. - Smoking status: contraindicated for smokers over 35 years of age. - Hepatic function: use with caution in patients with liver disease. - Drug interaction review: monitor concomitant use of enzyme‑inducing agents. - Store at room temperature: keep in the original packaging, protect from moisture and light.

Levonorgestrel/Ethinylestradiol can interact with other medicines, affecting its effectiveness or safety.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., rifampin, carbamazepine): may markedly reduce contraceptive efficacy. - Certain antiepileptic drugs (e.g., phenytoin, phenobarbital): can lower hormone levels.

Moderate Interactions (Monitor Closely): - Antibiotics such as ampicillin: may slightly decrease effectiveness. - Antifungal agents like fluconazole: can increase hormone concentrations. - Herbal supplements (e.g., St. John’s wort): may diminish contraceptive reliability.